Literature DB >> 17011982

Variations in exon 7 of the MSH2 gene and susceptibility to gastrointestinal cancer in a Chinese population.

Yimei Fan1, Xiaorong Liu, Huan Zhang, Jin Dai, Xiaomei Zhang, Ming Zhu, Xiang Gao, Yaping Wang.   

Abstract

Epidemiologic, structural, and bioinformatic analyses were used to evaluate variants in the MSH2 and MLH1 genes in 187 subjects with suspected hereditary gastrointestinal cancer in China. An increased frequency of variants was observed in exon 7 of the MSH2 gene; there was a statistical difference (P < 0.05) between the colorectal cancer (CRC) group (6/82, or 7.32%) or the gastric cancer (GC) group (8/105, or 7.62%) and the controls (1/112, or 0.89%). The odds ratio (OR) was 8.76 for CRC and 9.15 for GC, suggesting an association between the presence of variants in exon 7 of the MSH2 gene and risk of gastrointestinal cancer in the studied population. In addition, MSH2 1168T showed trends toward association with CRC and GC in young (<50 yr) sporadic disease patients (OR = 10.97 and 17.15, respectively). The c.1168C>T (p.Leu390Phe), c.1255C>A (p.Gln419Lys), and c.1261C>A (p.Leu421Met) in exon 7 and c.518T>G (p.Leu173Arg) in exon 3 of MSH2 were suspected as predisposing to gastrointestinal cancer. Variants c.505A>G (p.Ile169Val), c.1221C>G (p.Leu407Leu) and c.1223A>G (p.Tyr408Cys) in MSH2 and c.655 A>G (p.Ile219 Val) and c.927C>T (p.Pro309Pro) in MLH1 might be merely polymorphisms. Consequences of the variant c.2101C>A (p.Gln701Lys) in MLH1 remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17011982     DOI: 10.1016/j.cancergencyto.2006.05.010

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

Review 1.  Advances in the study of Lynch syndrome in China.

Authors:  Jun-Yu Lu; Jian-Qiu Sheng
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

2.  Non-truncating hMLH1 variants identified in Slovenian gastric cancer patients are not associated with Lynch Syndrome: a functional analysis report.

Authors:  Matjaz Vogelsang; Radovan Komel
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

3.  Germline promoter hypermethylation of tumor suppressor genes in gastric cancer.

Authors:  Pu-Yuan Wu; Zheng Zhang; Jing-Mei Wang; Wen-Wen Guo; Nong Xiao; Qiong He; Ya-Ping Wang; Yi-Mei Fan
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

4.  Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore.

Authors:  Hui-Ling Yap; Wei-Shieng Chieng; Jasmine Rui-Chen Lim; Robert Seng-Cheong Lim; Ross Soo; Jiayi Guo; Soo-Chin Lee
Journal:  Fam Cancer       Date:  2008-08-23       Impact factor: 2.375

5.  The MLH1 2101C>A (Q701K) variant increases the risk of gastric cancer in Chinese males.

Authors:  Wenxian Zhi; Binshuang Xue; Lifeng Wang; Nong Xiao; Qiong He; Yaping Wang; Yimei Fan
Journal:  BMC Gastroenterol       Date:  2011-12-03       Impact factor: 3.067

6.  Analysis of human MutS homolog 2 missense mutations in patients with colorectal cancer.

Authors:  Xiaomei Zhang; Senqing Chen; Jun Yu; Yuanying Zhang; Min Lv; Ming Zhu
Journal:  Oncol Lett       Date:  2018-03-02       Impact factor: 2.967

7.  Novel PHOX2B germline mutation in childhood medulloblastoma: a case report.

Authors:  Caiping Ke; Xiaoshun Shi; Allen Menglin Chen; Chaoming Li; Bifeng Jiang; Kailing Huang; Zhouxia Zheng; Yanhui Liu; Zhuona Chen; Yingjun Luo; Huaming Lin; Jiexia Zhang
Journal:  Hered Cancer Clin Pract       Date:  2021-01-19       Impact factor: 2.857

8.  Novel DNA variants and mutation frequencies of hMLH1 and hMSH2 genes in colorectal cancer in the Northeast China population.

Authors:  Fulan Hu; Dandan Li; Yibaina Wang; Xiaoping Yao; Wencui Zhang; Jing Liang; Chunqing Lin; Jiaojiao Ren; Lin Zhu; Zhiwei Wu; Shuying Li; Ye Li; Xiaojuan Zhao; Binbin Cui; Xinshu Dong; Suli Tian; Yashuang Zhao
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

9.  Missense mutations of MLH1 and MSH2 genes detected in patients with gastrointestinal cancer are associated with exonic splicing enhancers and silencers.

Authors:  Ming Zhu; Hui-Mei Chen; Ya-Ping Wang
Journal:  Oncol Lett       Date:  2013-03-11       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.